Skip to main content
Terug
Watch Compare

DIVERSIFIED HEALTHCARE TRUST

Datakwaliteit: 100%
Ook genoteerd als DHCNL Nasdaq
DHCNI
Nasdaq Financial Services Holding & Investment Offices
€ 17,85
▲ € 0,48 (2,79%)
Marktkapitalisatie: 4,29 B
Prijs
€ 17,85
Marktkapitalisatie
4,29 B
Dagbereik
€ 17,40 — € 17,85
52-Weeksbereik
€ 12,79 — € 18,29
Volume
16.154
Openen € 17,54
50D / 200D Gem.
€ 17,23
3,58% above
50D / 200D Gem.
€ 16,95
5,34% above

Quick Summary

Belangrijkste Punten

Revenue grew 2,68% annually over 5 years — modest growth
Negative free cash flow of -19,62 M

Groei

Revenue Growth (5Y)
2,68%
Onder sectorgemiddelde (5,83%)
Revenue (1Y)2,84%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-16,13%
Onder sectorgemiddelde (9,24%)
ROICN/A
Net Margin-18,59%
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Waardering

PE (TTM)
-15,00
Onder sectorgemiddelde (11,15)
P/B Ratio2,54
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Financial Services sector mediaan (2151 peers)
Metriek Aandeel Sector Mediaan
P/E -15,0 11,2
P/B 2,5 1,2
ROE % -16,1 9,2
Net Margin % -18,6 9,4
Rev Growth 5Y % 2,7 5,8
D/E — 0,5

All Fundamental Metrics
Growth
Revenue Growth (1Y) 2,84% Revenue Growth (3Y) 4,42%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 2,68% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,54 B Net Income (TTM) -285,89 M
ROE -16,13% ROA -6,06%
Gross Margin N/A Operating Margin N/A
Net Margin -18,59% Free Cash Flow (TTM) -19,62 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover 0,33
Working Capital N/A Tangible Book Value 1,67 B
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -15,00 Forward P/E N/A
P/B Ratio 2,54 P/S Ratio 2,79
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,46%
Market Cap 4,29 B Enterprise Value 4,09 B
Per Share
EPS (Diluted TTM) -1,19 Revenue / Share 6,40
FCF / Share -0,08 OCF / Share -0,08
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 6,86%
SBC-Adj. FCF N/A Growth Momentum 0,16

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,54 B 1,50 B 1,41 B 1,28 B 1,38 B
Net Income -285,89 M -370,26 M -293,57 M -15,77 M 174,52 M
EPS (Diluted) -1,19 -1,55 -1,23 -0,07 0,73
Gross Profit — — — — —
Operating Income — — — — —
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 261,92 M 284,96 M 284,08 M 239,28 M 271,13 M
Interest Expense 204,50 M 235,24 M 191,78 M 209,38 M 255,76 M
Income Tax 1,74 M 467.000,0 445.000,0 710.000,0 1,43 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 4,36 B 5,14 B 5,45 B 6,00 B 6,62 B
Total Liabilities 2,70 B 3,18 B 3,11 B 3,36 B 3,96 B
Shareholders' Equity 1,67 B 1,96 B 2,34 B 2,64 B 2,66 B
Total Debt 2,44 B 3,05 B — — —
Cash & Equivalents 105,41 M 144,58 M 245,94 M 658,07 M 634,85 M
Current Assets — — — — —
Current Liabilities — — — — —